Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Bioequivalence Study
Interventions
DRUG

D961H Sachet 20 mg

Each volunteer will receive a D961H sachet 20 mg once in the morning for 5 days.

DRUG

D961H HPMC capsule 20 mg

Each volunteer will receive a D961H HPMC capsule 20 mg once in the morning for 5 days.

Trial Locations (1)

Unknown

Research Unit, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY